Your browser doesn't support javascript.
loading
Permanent postoperative hypoparathyroidism: an analysis of prevalence and predictive factors for adequacy of control in a cohort of 260 patients.
Díez, Juan J; Anda, Emma; Sastre, Julia; Pérez Corral, Begoña; Álvarez-Escolá, Cristina; Manjón, Laura; Paja, Miguel; Sambo, Marcel; Santiago Fernández, Piedad; Blanco Carrera, Concepción; Galofré, Juan C; Navarro, Elena; Zafón, Carles; Sanz, Eva; Oleaga, Amelia; Bandrés, Orosia; Donnay, Sergio; Megía, Ana; Picallo, María; Sánchez Ragnarsson, Cecilia; Baena-Nieto, Gloria; Fernández-García, José Carlos; Lecumberri, Beatriz; Sahún de la Vega, Manel; Romero-Lluch, Ana R; Iglesias, Pedro.
Afiliación
  • Díez JJ; Department of Endocrinology, Hospital Universitario Ramón y Cajal, Madrid, Spain.
  • Anda E; Present address: Department of Endocrinology, Hospital Universitario Puerta de Hierro Majadahonda, Instituto de Investigación Sanitaria Puerta de Hierro Segovia de Arana, Madrid, Spain.
  • Sastre J; Department of Endocrinology, Complejo Hospitalario de Navarra, Pamplona, Spain.
  • Pérez Corral B; Department of Endocrinology, Complejo Hospitalario de Toledo, Toledo, Spain.
  • Álvarez-Escolá C; Department of Endocrinology, Complejo Asistencial Universitario de León, León, Spain.
  • Manjón L; Department of Endocrinology, Hospital Universitario La Paz, Madrid, Spain.
  • Paja M; Department of Endocrinology, Hospital Universitario Central de Asturias, Oviedo, Spain.
  • Sambo M; Department of Endocrinology, Hospital Universitario de Basurto, Bilbao, Spain.
  • Santiago Fernández P; Department of Endocrinology, Hospital Universitario Gregorio Marañón, Madrid, Spain.
  • Blanco Carrera C; Department of Endocrinology, Complejo Hospitalario de Jaén, Jaén, Spain.
  • Galofré JC; Department of Endocrinology, Hospital Universitario Virgen de las Nieves, Granada, Spain.
  • Navarro E; Department of Endocrinology, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, Spain.
  • Zafón C; Department of Endocrinology, Clínica Universidad de Navarra, Pamplona, Spain.
  • Sanz E; Department of Endocrinology, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
  • Oleaga A; Department of Endocrinology, Hospital Universitario Vall d'Hebron, Barcelona, Spain.
  • Bandrés O; Department of Endocrinology, Hospital Universitario Vall d'Hebron, Barcelona, Spain.
  • Donnay S; Department of Endocrinology, Hospital Universitario de Basurto, Bilbao, Spain.
  • Megía A; Department of Endocrinology, Hospital Royo Villanova, Zaragoza, Spain.
  • Picallo M; Department of Endocrinology, Fundación Hospital de Alcorcón, Alcorcón, Madrid, Spain.
  • Sánchez Ragnarsson C; Department of Endocrinology, Hospital Universitari de Tarragona Joan XXIII, IISPV, Universitat Rovira i Virgili, Ciberdem, Tarragona, Spain.
  • Baena-Nieto G; Department of Endocrinology, Hospital Universitario Gregorio Marañón, Madrid, Spain.
  • Fernández-García JC; Department of Endocrinology, Hospital Universitario Central de Asturias, Oviedo, Spain.
  • Lecumberri B; Department of Endocrinology, Hospital de Jerez, Jerez de la Frontera, Cádiz, Spain.
  • Sahún de la Vega M; Department of Endocrinology, Hospital Universitario Virgen de la Victoria, Málaga, Spain.
  • Romero-Lluch AR; Department of Endocrinology, Hospital Universitario La Paz, Madrid, Spain.
  • Iglesias P; Department of Endocrinology, Hospital Moisès Broggi, Sant Joan Despí, Barcelona, Spain.
Gland Surg ; 9(5): 1380-1388, 2020 Oct.
Article en En | MEDLINE | ID: mdl-33224813
BACKGROUND: Recent guidelines for the treatment of hypoparathyroidism emphasize the need for long-term disease control, avoiding symptoms and hypocalcaemia. Our aim has been to analyze the prevalence of poor disease control in a national cohort of patients with hypoparathyroidism, as well as to evaluate predictive variables of inadequate disease control. METHODS: From a nation-wide observational study including a cohort of 1792 patients undergoing total thyroidectomy, we selected 260 subjects [207 women and 53 men, aged (mean ± SD) 47.2±14.8 years] diagnosed with permanent hypoparathyroidism. In every patient demographic data and details on surgical procedure, histopathology, calcium (Ca) metabolism, and therapy with Ca and calcitriol were retrospectively collected. A patient was considered not adequately controlled (NAC) if presented symptoms of hypocalcemia or biochemical data showing low serum Ca levels or high urinary Ca excretion. RESULTS: Two hundred and twenty-one (85.0%) patients were adequately controlled (AC) and 39 (15.0%) were NAC. Comparison between AC and NAC patients did not show any significant difference in demographic, surgical, and pathological features. Rate of hospitalization during follow-up was significantly higher among NAC patients in comparison with AC patients (35.9% vs. 10.9%, P<0.001). Dose of oral Ca and calcitriol were also significantly higher in NAC subjects. In a subgroup of 129 patients with serum parathyroid hormone (PTH) levels available, we found that NAC patients exhibited significantly lower postoperative PTH concentrations than AC patients [median (interquartile range) 3 (1.9-7.8) vs. 6.9 (3.0-11) pg/mL; P=0.009]. CONCLUSIONS: In a nation-wide cohort of 260 subjects with definitive hypoparathyroidism, 15% of them had poor disease control. These patients required higher doses of oral Ca and calcitriol, had higher rate of hospitalization during follow-up and showed lower PTH concentrations in the postoperative period.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Guideline / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Gland Surg Año: 2020 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Guideline / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Gland Surg Año: 2020 Tipo del documento: Article País de afiliación: España